Atul Bedi

5.7k total citations · 3 hit papers
29 papers, 4.8k citations indexed

About

Atul Bedi is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Atul Bedi has authored 29 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Atul Bedi's work include Cell death mechanisms and regulation (10 papers), Cancer-related Molecular Pathways (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Atul Bedi is often cited by papers focused on Cell death mechanisms and regulation (10 papers), Cancer-related Molecular Pathways (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Atul Bedi collaborates with scholars based in United States, Russia and United Kingdom. Atul Bedi's co-authors include Rajani Ravi, Qinwen Zeng, Bijoyesh Mookerjee, Gregg L. Semenza, Zaver M. Bhujwalla, Dmitri Artemov, Thomas R. Sutter, Ashima Madan, Larry E. Dillehay and Michael B. Kastan and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Atul Bedi

29 papers receiving 4.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conversion of Bcl-2 to a Bax-like Death Effector by Caspases

1997 943 citations Rajani Ravi, Atul Bedi et al. profile →
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.

2000 942 citations Rajani Ravi, Bijoyesh Mookerjee et al. PubMed profile →
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α

2000 831 citations Rajani Ravi, Bijoyesh Mookerjee et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Atul Bedi	3.2k	2.0k	1.6k	639	418	29	4.8k
Oliver Stoeltzing	3.0k 0.9×	1.4k 0.7×	1.6k 1.0×	383 0.6×	538 1.3×	73	4.6k
Gong Yang	2.8k 0.9×	1.5k 0.7×	1.4k 0.9×	625 1.0×	461 1.1×	108	5.0k
Lindsey D. Mayo	4.6k 1.5×	1.5k 0.8×	2.4k 1.5×	934 1.5×	302 0.7×	61	6.3k
Sophie Vasseur	2.6k 0.8×	1.7k 0.8×	1.4k 0.9×	586 0.9×	298 0.7×	60	4.6k
Wolfgang Mikulits	4.1k 1.3×	1.6k 0.8×	2.4k 1.5×	822 1.3×	646 1.5×	116	6.9k
Kanaga Sabapathy	3.5k 1.1×	1.2k 0.6×	2.1k 1.3×	755 1.2×	221 0.5×	96	5.0k
Jiong Deng	3.3k 1.0×	1.2k 0.6×	2.0k 1.2×	644 1.0×	469 1.1×	61	4.8k
Hirofumi Arakawa	4.2k 1.3×	1.1k 0.6×	2.5k 1.5×	429 0.7×	350 0.8×	68	6.0k
Dung‐Fang Lee	4.9k 1.5×	1.4k 0.7×	1.6k 1.0×	660 1.0×	391 0.9×	87	6.3k
Shiwu Zhang	2.8k 0.9×	1.5k 0.8×	1.7k 1.0×	564 0.9×	668 1.6×	169	4.7k

Countries citing papers authored by Atul Bedi

Since Specialization

Citations

This map shows the geographic impact of Atul Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atul Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atul Bedi more than expected).

Fields of papers citing papers by Atul Bedi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atul Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atul Bedi. The network helps show where Atul Bedi may publish in the future.

Co-authorship network of co-authors of Atul Bedi

This figure shows the co-authorship network connecting the top 25 collaborators of Atul Bedi. A scholar is included among the top collaborators of Atul Bedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atul Bedi. Atul Bedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ravi, Rajani, Kimberly Noonan, Vui Pham, et al.. (2018). Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy. Nature Communications. 9(1). 741–741. 250 indexed citations

Ozawa, Hiroyuki, Evgeny Izumchenko, Eugene Makarev, et al.. (2017). SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. Clinical Cancer Research. 23(17). 5162–5175. 57 indexed citations

Makarev, Eugene, Adrian D. Schubert, Riya R. Kanherkar, et al.. (2017). In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia. Cell Death Discovery. 3(1). 17022–17022. 26 indexed citations

Gilbert, Jill, Michael J. Schell, Xiuhua Zhao, et al.. (2015). A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma. Oral Oncology. 51(4). 376–382. 41 indexed citations

Izumchenko, Evgeny, Xiaofei Chang, Mariana Brait, et al.. (2015). Targeted sequencing reveals clonal genetic changes in the progression of early lung neoplasms and paired circulating DNA. Nature Communications. 6(1). 8258–8258. 101 indexed citations

Izumchenko, Evgeny, Xiaofei Chang, Christina Michailidi, et al.. (2014). The TGFβ–miR200–MIG6 Pathway Orchestrates the EMT-Associated Kinase Switch That Induces Resistance to EGFR Inhibitors. Cancer Research. 74(14). 3995–4005. 104 indexed citations

Chang, Xiaofei, Eugene Izumchenko, Luisa M. Solis, et al.. (2013). The Relative Expression of Mig6 and EGFR Is Associated with Resistance to EGFR Kinase Inhibitors. PLoS ONE. 8(7). e68966–e68966. 25 indexed citations

Bedi, Atul, Xiaofei Chang, Kimberly Noonan, et al.. (2012). Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy. Molecular Cancer Therapeutics. 11(11). 2429–2439. 59 indexed citations

Chang, Xiaofei, Rajani Ravi, Vui Pham, et al.. (2011). Adenylate Kinase 3 Sensitizes Cells to Cigarette Smoke Condensate Vapor Induced Cisplatin Resistance. PLoS ONE. 6(6). e20806–e20806. 38 indexed citations

10.

Chatterjee, Aditi, Xiaofei Chang, Tanusree Sen, et al.. (2010). Regulation of p53 Family Member Isoform ΔNp63α by the Nuclear Factor-κB Targeting Kinase IκB Kinase β. Cancer Research. 70(4). 1419–1429. 35 indexed citations

11.

Ravi, Rajani & Atul Bedi. (2002). Potential methods to circumvent blocks in apoptosis in lymphomas. Current Opinion in Oncology. 14(5). 490–503. 11 indexed citations

12.

Ravi, Rajani, Gauri C. Bedi, Laura Engstrom, et al.. (2001). Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB. Nature Cell Biology. 3(4). 409–416. 269 indexed citations

13.

Semenza, Gregg L., Dmitri Artemov, Atul Bedi, et al.. (2001). ‘The Metabolism of Tumours’: 70 Years Later. Novartis Foundation symposium. 240. 251–264. 167 indexed citations

14.

Gladstone, Douglas E., Atul Bedi, Carole B. Miller, et al.. (1999). Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia. Biology of Blood and Marrow Transplantation. 5(6). 394–399. 11 indexed citations

15.

Fuchs, Ephraim J., et al.. (1997). p53-dependent DNA damage-induced apoptosis requires Fas/APO-1-independent activation of CPP32beta.. PubMed. 57(13). 2550–4. 118 indexed citations

16.

Akhtar, Adil, Gauri C. Bedi, David Sidransky, et al.. (1996). Selective radiosensitization of p53–deficient cells by caffeine–mediated activation of p34cdc2 kinase. Nature Medicine. 2(10). 1140–1143. 139 indexed citations

17.

Bedi, Atul & Saul J. Sharkis. (1995). Mechanisms of cell commitment in myeloid cell differentiation. Current Opinion in Hematology. 2(1). 12–21. 17 indexed citations

18.

Pasricha, Pankaj J., Atul Bedi, Kathryn L. O’Connor, et al.. (1995). The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology. 109(3). 994–998. 212 indexed citations

19.

Bedi, Atul, et al.. (1994). Biology of chronic myeloid leukemia and its relevance to autologous bone marrow transplantation. Current Opinion in Oncology. 6(2). 122–126. 3 indexed citations

20.

Bedi, Atul, Constance A. Griffin, James Barber, et al.. (1994). Growth factor-mediated terminal differentiation of chronic myeloid leukemia.. PubMed. 54(21). 5535–8. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact